Charles Craddock

39PUBLICATIONS
194CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyHaematologyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|May 22, 2026
Initial leukemic epigenomic state determines hypomethylating agent response.

|Dec 04, 2025
Frequency and impact of somatic co-occurring mutations on post-transplant outcomes in acute myeloid leukemia: a multicenter registry analysis on behalf of the EBMT ALWP.

Ali Bazarbachi, Jacques-Emmanuel Galimard, Iman Abou Dalle

|May 22, 2025
A revised prognostic model for patients with acute myeloid leukemia and first relapse.

Niek G van der Maas, Dimitri Breems, Clara P W Klerk

|Sep 06, 2024
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in adults over 70 years old.

Roland B Walter, Victoria Potter, Charles Craddock

|Sep 04, 2024
Risk Stratification in Older Intensively Treated Patients With AML.

Jurjen Versluis, Marlen Metzner, Ariel Wang

|Aug 12, 2024
Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations.

Hartmut Döhner, Courtney D DiNardo, Frederick R Appelbaum

Pageof 7

Frequent Collaborators

10 joint publications

Mohamad Mohty

9 joint publications

Arnon Nagler

8 joint publications

Myriam Labopin

7 joint publications

Fabio Ciceri